| Ticker Details |
|
GRAIL, Inc. Common Stock
|
| IPO Date: |
June 25, 2024 |
| Sector: |
Healthcare |
| Industry: |
Diagnostics and Research |
| Market Cap: |
$1.95B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.81 | 4.34%
|
| Avg Daily Range (30 D): |
$1.75 | 3.46%
|
| Avg Daily Range (90 D): |
$2.71 | 3.51%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.07M |
| Avg Daily Volume (30 D): |
.87M |
| Avg Daily Volume (90 D): |
.98M |
| Trade Size |
| Avg Trade Size (Sh.): |
65 |
| Avg Trade Size (Sh.) (30 D): |
50 |
| Avg Trade Size (Sh.) (90 D): |
51 |
| Institutional Trades |
| Total Institutional Trades: |
881 |
| Avg Institutional Trade: |
$3.06M |
| Avg Institutional Trade (30 D): |
$4.03M |
| Avg Institutional Trade (90 D): |
$4.78M |
| Avg Institutional Trade Volume: |
.07M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.53M |
| Avg Closing Trade (30 D): |
$7.45M |
| Avg Closing Trade (90 D): |
$8.7M |
| Avg Closing Volume: |
101.2K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-11.11
|
$-2.38
|
$-11.11
|
|
Diluted EPS
|
$-11.11
|
$-2.38
|
$-11.11
|
|
Revenue
|
$147.17M
|
$43.6M
|
$147.17M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-408.35M
|
$-99.18M
|
$-408.35M
|
|
Operating Income / Loss
|
$-562.16M
|
$-124.41M
|
$-562.16M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$39.12M
|
$38.97M
|
$39.12M
|
|
PE Ratio
|
|
|
|
|
|
|